| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.32041 |
| P698 | PubMed publication ID | 30840315 |
| P50 | author | Marc Diederich | Q30537277 |
| P2093 | author name string | Mario Dicato | |
| Michael Schnekenburger | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Epigenetics Offer New Horizons for Colorectal Cancer Prevention | Q22252606 | ||
| Epigenetic effects of green tea polyphenols in cancer | Q24568216 | ||
| Cancer immunoediting from immune surveillance to immune escape | Q24655415 | ||
| Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy | Q26746038 | ||
| Anticancer Molecular Mechanisms of Resveratrol | Q26752323 | ||
| Epigenomics of leukemia: from mechanisms to therapeutic applications | Q26823403 | ||
| HDAC inhibitors and immunotherapy; a double edged sword? | Q26853102 | ||
| Innate and adaptive immune cells in the tumor microenvironment | Q27008342 | ||
| Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer | Q28073020 | ||
| Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells | Q28257534 | ||
| Immunogenic cell death in cancer therapy | Q29620118 | ||
| Induction of MAGE-3 expression in lung and esophageal cancer cells | Q32054392 | ||
| Epigenetic Strategies to Boost Cancer Immunotherapies. | Q33838340 | ||
| Curcumin: An age-old anti-inflammatory and anti-neoplastic agent | Q33896515 | ||
| Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis | Q33909418 | ||
| Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression | Q33999130 | ||
| Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts | Q34105756 | ||
| CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers | Q34256170 | ||
| FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice | Q34340614 | ||
| Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis | Q34613208 | ||
| The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. | Q34982031 | ||
| Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells | Q35136002 | ||
| Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. | Q35234948 | ||
| DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. | Q35571274 | ||
| The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells | Q46367607 | ||
| Immunomodulatory effects of curcumin: in-vivo | Q46665393 | ||
| Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells | Q46712356 | ||
| Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells | Q46742232 | ||
| Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma | Q46815317 | ||
| Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors | Q47225796 | ||
| Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways. | Q47407575 | ||
| Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice | Q47951320 | ||
| Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia. | Q50482508 | ||
| Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro. | Q51286736 | ||
| Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma. | Q51633659 | ||
| Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. | Q52374596 | ||
| Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers. | Q55209672 | ||
| Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro | Q56897901 | ||
| An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs | Q58610233 | ||
| Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin | Q81270631 | ||
| Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice | Q82772904 | ||
| The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance | Q86035624 | ||
| Curcumin and dietary polyphenol research: beyond drug discovery | Q88064814 | ||
| Targeting Epigenetics in Cancer | Q89169966 | ||
| Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. | Q35740104 | ||
| Histone deacetylase modulators provided by Mother Nature | Q36049516 | ||
| Chemopreventive and therapeutic effects of curcumin | Q36128979 | ||
| Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells | Q36224502 | ||
| Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity | Q36353207 | ||
| Curcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma | Q36413332 | ||
| Epigenetic regulation of immune escape genes in cancer | Q36471068 | ||
| Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. | Q36881910 | ||
| Challenges and prospects of immunotherapy as cancer treatment. | Q36919456 | ||
| Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers | Q37114055 | ||
| Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. | Q37227553 | ||
| IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer | Q37295663 | ||
| Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescence | Q37317571 | ||
| Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization | Q37360069 | ||
| Targeting microRNAs: a new action mechanism of natural compounds. | Q37716654 | ||
| The biology of cancer testis antigens: putative function, regulation and therapeutic potential | Q37849976 | ||
| MicroRNAs in cancer management and their modulation by dietary agents | Q37985206 | ||
| Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. | Q37998751 | ||
| Chromatin-modifying agents in anti-cancer therapy | Q38012989 | ||
| Curcumin as a regulator of epigenetic events | Q38113525 | ||
| Epigenetic drugs as immunomodulators for combination therapies in solid tumors | Q38175265 | ||
| Plant-derived epigenetic modulators for cancer treatment and prevention | Q38201994 | ||
| Epigenetic modulators from "The Big Blue": a treasure to fight against cancer | Q38223159 | ||
| Histone deacetylase 6 in health and disease | Q38357741 | ||
| Immune evasion in cancer: Mechanistic basis and therapeutic strategies. | Q38394302 | ||
| TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. | Q38491055 | ||
| Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review | Q38572855 | ||
| Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments | Q38572911 | ||
| Role of Histone Acetylation in Cell Cycle Regulation | Q38572917 | ||
| Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. | Q38668305 | ||
| Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma | Q38740003 | ||
| Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model | Q38918196 | ||
| Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages | Q38973749 | ||
| Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy. | Q38988078 | ||
| MicroRNAs at the epicenter of intestinal homeostasis | Q39117431 | ||
| Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression | Q39214234 | ||
| Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase | Q39216146 | ||
| TET family dioxygenases and DNA demethylation in stem cells and cancers | Q39268149 | ||
| Epigenetics and immunotherapy: The current state of play | Q39311485 | ||
| Targeting the MAGE A3 antigen in pancreatic cancer | Q39318470 | ||
| Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy | Q39337489 | ||
| Epigenetic modulation in cancer immunotherapy | Q39369845 | ||
| MicroRNA: A novel target of curcumin in cancer therapy | Q39375777 | ||
| Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors | Q39381872 | ||
| Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action. | Q39451732 | ||
| Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity | Q39557788 | ||
| Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules | Q39663619 | ||
| Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels | Q39670159 | ||
| Green Tea Catechin Metabolites Exert Immunoregulatory Effects on CD4(+) T Cell and Natural Killer Cell Activities. | Q39823634 | ||
| Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis | Q39896035 | ||
| Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. | Q39910403 | ||
| Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells | Q39948537 | ||
| Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours | Q40088428 | ||
| Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo | Q40107293 | ||
| Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells | Q40108262 | ||
| Expression of GAGE family proteins in malignant melanoma | Q40189201 | ||
| Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells | Q40281482 | ||
| A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray | Q40323085 | ||
| Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. | Q40344948 | ||
| Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment | Q40926199 | ||
| Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line. | Q41135519 | ||
| (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells | Q41582112 | ||
| HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma | Q41739174 | ||
| The role of polyphenols in modern nutrition | Q41978174 | ||
| Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis | Q42106350 | ||
| Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway | Q42371577 | ||
| An epigenetically altered tumor cell vaccine | Q42798885 | ||
| Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat | Q44807245 | ||
| Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells. | Q45196900 | ||
| Curcumin stability and its effect on glutathione S-transferase P1-1 mRNA expression in K562 cells | Q45230803 | ||
| HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. | Q46017171 | ||
| Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds | Q46300890 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1612-1628 | |
| P577 | publication date | 2019-03-06 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue? | |
| P478 | volume | 125 |
| Q91639454 | The roles of curcumin in regulating the tumor immunosuppressive microenvironment | cites work | P2860 |
Search more.